$HRGN
Harvard Apparatus Regenerative Technology Inc
Stock
$hrgn
2019 Q1 Form 10-K Financial Statement
#000114420419017039 Filed on March 29, 2019
Income Statement
Concept | 2019 Q1 | 2018 Q4 | 2018 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.000M | $952.0K | $3.925M |
YoY Change | 7.76% | -1.86% | 1.16% |
% of Gross Profit | |||
Research & Development | $1.034M | $1.148M | $3.916M |
YoY Change | 87.32% | 144.26% | -48.39% |
% of Gross Profit | |||
Depreciation & Amortization | $61.00K | $67.00K | $261.0K |
YoY Change | -3.17% | -16.25% | -36.8% |
% of Gross Profit | |||
Operating Expenses | $2.034M | $2.100M | $7.841M |
YoY Change | 37.43% | 45.83% | -31.63% |
Operating Profit | -$2.034M | -$7.841M | |
YoY Change | 37.43% | -31.63% | |
Interest Expense | $89.00K | ||
YoY Change | -72.19% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $107.0K | $176.0K | $312.0K |
YoY Change | -264.62% | -260.0% | -169.64% |
Pretax Income | -$1.927M | -$1.835M | -$7.529M |
YoY Change | 24.72% | 49.19% | -36.82% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$1.927M | -$1.835M | -$7.529M |
YoY Change | 24.72% | 49.19% | -36.82% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$321.0K | -$322.8K | -$1.687M |
COMMON SHARES | |||
Basic Shares Outstanding | 6.170M | 5.669M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2019 Q1 | 2018 Q4 | 2018 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.065M | $1.305M | $1.305M |
YoY Change | -62.23% | -67.7% | -67.68% |
Cash & Equivalents | $1.115M | $1.355M | |
Short-Term Investments | |||
Other Short-Term Assets | $549.0K | $90.00K | $673.0K |
YoY Change | 1425.0% | -15.09% | 79.47% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $114.0K | $176.0K | $176.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $1.728M | $2.154M | $2.154M |
YoY Change | -47.16% | -51.19% | -51.19% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $466.0K | $479.0K | $479.0K |
YoY Change | -21.02% | -24.21% | -24.21% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $609.0K | $479.0K | $479.0K |
YoY Change | 3.22% | -24.21% | -24.21% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.728M | $2.154M | $2.154M |
Total Long-Term Assets | $609.0K | $479.0K | $479.0K |
Total Assets | $2.337M | $2.633M | $2.633M |
YoY Change | -39.46% | -47.81% | -47.81% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $311.0K | $160.0K | $160.0K |
YoY Change | 29.58% | -82.67% | -82.67% |
Accrued Expenses | $540.0K | $404.0K | $404.0K |
YoY Change | 25.58% | 6.32% | 5.48% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $956.0K | $662.0K | $662.0K |
YoY Change | 18.17% | -59.19% | -59.19% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $44.00K | $0.00 | |
YoY Change | |||
Total Long-Term Liabilities | $44.00K | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $956.0K | $662.0K | $662.0K |
Total Long-Term Liabilities | $44.00K | $0.00 | $0.00 |
Total Liabilities | $1.000M | $662.0K | $662.0K |
YoY Change | 23.61% | -59.19% | -59.19% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$57.69M | -$55.76M | |
YoY Change | 15.89% | 15.61% | |
Common Stock | $62.00K | $57.00K | |
YoY Change | 113.79% | 128.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.337M | $1.971M | $1.971M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $2.337M | $2.633M | $2.633M |
YoY Change | -39.41% | -47.81% | -47.81% |
Cashflow Statement
Concept | 2019 Q1 | 2018 Q4 | 2018 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.927M | -$1.835M | -$7.529M |
YoY Change | 24.72% | 49.19% | -36.82% |
Depreciation, Depletion And Amortization | $61.00K | $67.00K | $261.0K |
YoY Change | -3.17% | -16.25% | -36.8% |
Cash From Operating Activities | -$1.216M | -$2.184M | -$7.638M |
YoY Change | -40.97% | 32.36% | -30.65% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $24.00K | -$4.000K | $131.0K |
YoY Change | 700.0% | -3.68% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $64.00K |
YoY Change | -100.0% | ||
Cash From Investing Activities | -$24.00K | -$4.000K | -$67.00K |
YoY Change | -152.17% | -50.74% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 1.000M | 0.000 | 5.022M |
YoY Change | 25.79% | -100.0% | -58.99% |
NET CHANGE | |||
Cash From Operating Activities | -1.216M | -2.184M | -7.638M |
Cash From Investing Activities | -24.00K | -4.000K | -67.00K |
Cash From Financing Activities | 1.000M | 0.000 | 5.022M |
Net Change In Cash | -240.0K | -2.188M | -2.683M |
YoY Change | -80.31% | -180.15% | -344.58% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.216M | -$2.184M | -$7.638M |
Capital Expenditures | $24.00K | -$4.000K | $131.0K |
Free Cash Flow | -$1.240M | -$2.180M | -$7.769M |
YoY Change | -39.89% | 32.12% | -30.32% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2018Q4 | us-gaap |
Cash
Cash
|
1305000 | |
CY2017Q4 | us-gaap |
Cash
Cash
|
4038000 | |
CY2018Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
50000 | |
CY2017Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
0 | |
CY2018Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
176000 | |
CY2017Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
0 | |
CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
623000 | |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
375000 | |
CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2154000 | |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4413000 | |
CY2018Q4 | us-gaap |
Assets
Assets
|
2633000 | |
CY2017Q4 | us-gaap |
Assets
Assets
|
5045000 | |
CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
160000 | |
CY2017Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
16000 | |
CY2018Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
404000 | |
CY2017Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
383000 | |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
923000 | |
CY2018Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
0 | |
CY2017Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
300000 | |
CY2018Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
404000 | |
CY2017Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
383000 | |
CY2018Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
98000 | |
CY2017Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
16000 | |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
662000 | |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1622000 | |
CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
662000 | |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
1622000 | |
CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
57000 | |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
25000 | |
CY2018Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
57677000 | |
CY2017Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
50157000 | |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-55763000 | |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-48234000 | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1971000 | |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2633000 | |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5045000 | |
CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5669645 | |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2507304 | |
CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5669645 | |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2507304 | |
CY2018 | us-gaap |
Revenues
Revenues
|
0 | |
CY2017 | us-gaap |
Revenues
Revenues
|
0 | |
CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3916000 | |
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7588000 | |
CY2018 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3925000 | |
CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3880000 | |
CY2018 | us-gaap |
Operating Expenses
OperatingExpenses
|
7841000 | |
CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
11468000 | |
CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7841000 | |
CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-11468000 | |
CY2018 | bstg |
Grant Income
GrantIncome
|
401000 | |
CY2017 | bstg |
Grant Income
GrantIncome
|
0 | |
CY2018 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
82000 | |
CY2017 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
337000 | |
CY2018 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
312000 | |
CY2017 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-448000 | |
CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
755000 | |
CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
693000 | |
CY2018 | us-gaap |
Depreciation
Depreciation
|
261000 | |
CY2017 | us-gaap |
Depreciation
Depreciation
|
413000 | |
CY2018 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-7000 | |
CY2017 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-160000 | |
CY2018 | bstg |
Fair Value Adjustment Of Warrants Gross
FairValueAdjustmentOfWarrantsGross
|
82000 | |
CY2017 | bstg |
Fair Value Adjustment Of Warrants Gross
FairValueAdjustmentOfWarrantsGross
|
337000 | |
CY2018 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | |
CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-42000 | |
CY2018 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
317000 | |
CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-2000 | |
CY2018 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-20000 | |
CY2017 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-126000 | |
CY2018 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-763000 | |
CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-43000 | |
CY2018 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
22000 | |
CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-828000 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7638000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-11014000 | |
CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
131000 | |
CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
136000 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-67000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-136000 | |
CY2018 | bstg |
Proceeds From Issuance Of Series D Convertible Preferred Stock Common Stock And Warrants Net
ProceedsFromIssuanceOfSeriesDConvertiblePreferredStockCommonStockAndWarrantsNet
|
0 | |
CY2017 | bstg |
Proceeds From Issuance Of Series D Convertible Preferred Stock Common Stock And Warrants Net
ProceedsFromIssuanceOfSeriesDConvertiblePreferredStockCommonStockAndWarrantsNet
|
4086000 | |
CY2018 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
5322000 | |
CY2017 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
6801000 | |
CY2018 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | |
CY2017 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
1060000 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5022000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12247000 | |
CY2018 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2683000 | |
CY2017 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1097000 | |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4038000 | |
CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2941000 | |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1355000 | |
CY2018 | bstg |
Reclassification Of Warrants To Additional Paid In Capital Upon Modification
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponModification
|
0 | |
CY2018 | bstg |
Reclassification Of Warrants To Additional Paid In Capital Upon Exercise
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponExercise
|
0 | |
CY2018 | bstg |
Receivable For Sale Of Equipment Included Loss On Sale Of Equipment
ReceivableForSaleOfEquipmentIncludedLossOnSaleOfEquipment
|
0 | |
CY2017 | bstg |
Receivable For Sale Of Equipment Included Loss On Sale Of Equipment
ReceivableForSaleOfEquipmentIncludedLossOnSaleOfEquipment
|
49000 | |
CY2018 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
0 | |
CY2017 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
4000 | |
CY2018 | bstg |
Fair Value Of Liability Warrants Issued In Connection With Issuance Of Common Stock
FairValueOfLiabilityWarrantsIssuedInConnectionWithIssuanceOfCommonStock
|
0 | |
CY2017 | bstg |
Fair Value Of Liability Warrants Issued In Connection With Issuance Of Common Stock
FairValueOfLiabilityWarrantsIssuedInConnectionWithIssuanceOfCommonStock
|
3787000 | |
CY2018 | us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
176000 | |
CY2017 | us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
0 | |
CY2018 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
64000 | |
CY2017 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | |
CY2018 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
1475000 | |
CY2017 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
0 | |
CY2018 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
-300000 | |
CY2017 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
300000 | |
CY2018 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.38in; margin-right: 0px; background: none;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt "times new roman", times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px;">Financial investments that potentially subject the Company to credit risk consists of cash. Deposits at banks may exceed the insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2017Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
253000 | |
bstg |
Maximum Research And Development Expenses Reimbursement
MaximumResearchAndDevelopmentExpensesReimbursement
|
225000 | ||
CY2018Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
50000 | |
CY2018 | bstg |
Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4. Prepaid Expenses and Other Current Assets</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses and other current assets consist of the following:</div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 80%;;text-align:left;"><tr><td style="border-bottom: none; border-top: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="border-top: none; padding: 0in 0in 1pt; vertical-align: bottom;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 11%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">December 31,</div></div></div></td><td style="border-top: none; padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td></tr><tr><td style="border-bottom: none; border-top: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 11%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">2018</div></div></div></td><td style="border-top: 0px none; padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td><td style="border-top: 0px none; padding: 0in 0in 1pt; vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 11%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">2017</div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td></tr><tr><td style="border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="padding: 0in; vertical-align: bottom;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td><td colspan="6" style="border-bottom: none; border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 11%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(in thousands)</div></div></div></td><td style="padding: 0in; vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;">Insurance</div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; width: 10%; white-space: nowrap; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">347</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; white-space: nowrap; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; width: 1%; white-space: nowrap; text-align: left;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; width: 10%; white-space: nowrap; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">253</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; white-space: nowrap; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;">Sponsored research</div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(255, 255, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">149</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(255, 255, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(255, 255, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;">Annual contracts</div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">37</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">16</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-bottom: none; border-top: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;">Other current assets</div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1pt; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">90</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">106</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 74%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;">Total prepaid expenses and other current assets</div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">623</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: right;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">375</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2018Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
347000 | |
CY2018Q4 | bstg |
Prepaid Sponsored Research
PrepaidSponsoredResearch
|
149000 | |
CY2017Q4 | bstg |
Prepaid Sponsored Research
PrepaidSponsoredResearch
|
0 | |
CY2018Q4 | bstg |
Prepaid Annual Contracts
PrepaidAnnualContracts
|
37000 | |
CY2017Q4 | bstg |
Prepaid Annual Contracts
PrepaidAnnualContracts
|
16000 | |
CY2018Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
90000 | |
CY2017Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
106000 | |
CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2478000 | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2398000 | |
CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1999000 | |
CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1766000 | |
CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
479000 | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
632000 | |
CY2018Q4 | bstg |
Accrued Payroll Current
AccruedPayrollCurrent
|
-113000 | |
CY2017Q4 | bstg |
Accrued Payroll Current
AccruedPayrollCurrent
|
-145000 | |
CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
110000 | |
CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
133000 | |
CY2018Q4 | bstg |
Accrued Advisory Costs Current
AccruedAdvisoryCostsCurrent
|
-79000 | |
CY2017Q4 | bstg |
Accrued Advisory Costs Current
AccruedAdvisoryCostsCurrent
|
-25000 | |
CY2018Q4 | bstg |
Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
|
-40000 | |
CY2017Q4 | bstg |
Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
|
0 | |
CY2018Q4 | bstg |
Accrued Research Costs Current
AccruedResearchCostsCurrent
|
-26000 | |
CY2017Q4 | bstg |
Accrued Research Costs Current
AccruedResearchCostsCurrent
|
-64000 | |
CY2018Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
36000 | |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
102000 | |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
42000 | |
CY2017Q3 | bstg |
Warrants To Be Modified Number
WarrantsToBeModifiedNumber
|
952184 | |
CY2018 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
102000 | |
CY2017 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
59000 | |
CY2018 | bstg |
Fair Value Assumptions Risk Free Interest Rat
FairValueAssumptionsRiskFreeInterestRat
|
0.0246 | |
CY2017 | bstg |
Fair Value Assumptions Risk Free Interest Rat
FairValueAssumptionsRiskFreeInterestRat
|
0.0209 | |
CY2018 | bstg |
Fair Value Assumptions Expected Volatility Rates
FairValueAssumptionsExpectedVolatilityRates
|
121.9 | |
CY2017 | bstg |
Fair Value Assumptions Expected Volatility Rates
FairValueAssumptionsExpectedVolatilityRates
|
85.0 | |
CY2018 | bstg |
Fair Value Assumptions Expected Terms
FairValueAssumptionsExpectedTerms
|
P3Y1M6D | |
CY2017 | bstg |
Fair Value Assumptions Expected Terms
FairValueAssumptionsExpectedTerms
|
P4Y1M6D | |
CY2018 | bstg |
Fair Value Assumptions Expected Dividend Rates
FairValueAssumptionsExpectedDividendRates
|
0 | |
CY2017 | bstg |
Fair Value Assumptions Expected Dividend Rates
FairValueAssumptionsExpectedDividendRates
|
0 | |
CY2018Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
8.00 | |
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
8.00 | |
CY2018Q4 | us-gaap |
Share Price
SharePrice
|
2.06 | |
CY2017Q4 | us-gaap |
Share Price
SharePrice
|
0.87 | |
CY2018Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
92212 | |
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
92212 | |
CY2016Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
605000 | |
CY2017 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
|
3787000 | |
CY2017 | bstg |
Reclassification Of Warrants To Additional Paid In Capital Upon Modification
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponModification
|
3746000 | |
CY2017 | bstg |
Reclassification Of Warrants To Additional Paid In Capital Upon Exercise
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponExercise
|
581000 | |
CY2017 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-49000 | |
CY2017Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
16000 | |
CY2018 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
82000 | |
CY2018Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
98000 | |
CY2017Q2 | bstg |
Warrants To Be Modified Number
WarrantsToBeModifiedNumber
|
952184 | |
CY2017 | bstg |
Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Exercises In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod
|
132367 | |
CY2017Q4 | bstg |
Adjustments To Additional Paid In Capital Warrants Modified
AdjustmentsToAdditionalPaidInCapitalWarrantsModified
|
3700000 | |
CY2017Q4 | bstg |
Warrants To Be Remeasured Number
WarrantsToBeRemeasuredNumber
|
92213 | |
CY2017 | bstg |
Class Of Warrant Or Right Issuance Cost
ClassOfWarrantOrRightIssuanceCost
|
385000 | |
CY2018 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1581000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-4051000 | |
CY2018 | bstg |
Effective Income Tax Rate Reconciliation Change In Deferred Income Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInDeferredIncomeTaxRate
|
0 | |
CY2017 | bstg |
Effective Income Tax Rate Reconciliation Change In Deferred Income Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInDeferredIncomeTaxRate
|
5652000 | |
CY2018 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-476000 | |
CY2017 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-716000 | |
CY2018 | bstg |
Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants
|
24000 | |
CY2017 | bstg |
Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants
|
143000 | |
CY2018 | us-gaap |
Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
|
-224000 | |
CY2017 | us-gaap |
Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
|
-452000 | |
CY2018 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
671000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-1305000 | |
CY2018 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6819000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
4939000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2021000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
56000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
13835000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | |
CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7529000 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2018 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
700000 | |
CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1100000 | |
CY2018 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
95000 | |
CY2017 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
100000 | |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
518000 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
2.00 | |
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
3108000 | |
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.00 | |
CY2017Q4 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
4100000 | |
CY2017Q4 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2100000 | |
CY2018Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
3.60 | |
CY2018Q2 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
3600000 | |
CY2018Q2 | us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
3108000 | |
CY2018Q2 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
1554000 | |
CY2018Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3400000 | |
CY2018Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
250000 | |
CY2018Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
3.60 | |
CY2018Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
800000 | |
CY2018Q2 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
900000 | |
CY2018Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
3.60 | |
CY2018Q2 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
3600000 | |
CY2018Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3400000 | |
CY2018Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1000000 | |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11916000 | |
CY2018 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4463000 | |
CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1797000 | |
CY2018 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.69 | |
CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-6.63 | |
CY2018 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5764365 | |
CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5839996 | |
CY2017Q4 | us-gaap |
Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
|
20 | |
CY2017Q4 | us-gaap |
Restructuring Costs
RestructuringCosts
|
99000 | |
CY2017Q4 | us-gaap |
Restructuring And Related Cost Description
RestructuringAndRelatedCostDescription
|
In addition, officers of the Company agreed to a temporary reduction in their salaries, by 50%, effective November 2017. | |
CY2018Q1 | bstg |
Percentage Of Salary Of Officers On Contracted Rate
PercentageOfSalaryOfOfficersOnContractedRate
|
0.8 | |
CY2018 | us-gaap |
Officers Compensation
OfficersCompensation
|
104000 | |
CY2018 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-7000 | |
CY2017 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-111000 | |
CY2018 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-7000 | |
CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-111000 | |
CY2018 | bstg |
Product Distribution Agreement Term
ProductDistributionAgreementTerm
|
P10Y | |
CY2017Q4 | us-gaap |
Due From Related Parties Current
DueFromRelatedPartiesCurrent
|
300000 | |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1774000 | |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
693000 | |
CY2017 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
13000 | |
CY2017 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3891000 | |
CY2017 | bstg |
Reclassification Of Warrants To Additional Paid In Capital Upon Modification
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponModification
|
3746000 | |
CY2017 | bstg |
Reclassification Of Warrants To Additional Paid In Capital Upon Exercise
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponExercise
|
581000 | |
CY2017 | bstg |
Stock Issued During Period Value Of Common Stock Upon Warrant Exercises
StockIssuedDuringPeriodValueOfCommonStockUponWarrantExercises
|
1060000 | |
CY2017 | bstg |
Stock Issued During Period Value Of Series D Convertible Preferred Net Of Offering Costs
StockIssuedDuringPeriodValueOfSeriesDConvertiblePreferredNetOfOfferingCosts
|
1475000 | |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2106000 | |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3423000 | |
CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
755000 | |
CY2018 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | |
CY2018 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
5271000 | |
CY2018 | bstg |
Stock Issued During The Period Conversion Of Preferred Stock
StockIssuedDuringThePeriodConversionOfPreferredStock
|
0 | |
CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
51000 | |
CY2018 | dei |
Document Type
DocumentType
|
10-K | |
CY2018 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2018 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-12-31 | |
CY2018 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
CY2018 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2018 | dei |
Entity Registrant Name
EntityRegistrantName
|
Biostage, Inc. | |
CY2018 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001563665 | |
CY2018 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2018 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2018 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2018 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2018 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2018Q2 | dei |
Entity Public Float
EntityPublicFloat
|
12553138 | |
CY2018 | dei |
Trading Symbol
TradingSymbol
|
BSTG | |
CY2019Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
6169645 | |
CY2018 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2018 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2018 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | |
CY2018 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2018Q4 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Description And Terms
ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms
|
On October 26, 2018, the Company was awarded Phase II of the SBIR grant for $1.1 million to support development, testing, and translation to the clinic through September 2019. The Phase II grant includes an additional $0.5 million for future period support through September 2020, subject to availability of funding and satisfactory progress on the project. Accordingly, the SBIR grant has the potential to provide a total award of approximately $1.8 million. | |
CY2018 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
55000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
729000 | |
CY2018 | bstg |
Decrease In Deferred Tax Assets
DecreaseInDeferredTaxAssets
|
5800000 | |
CY2018 | bstg |
Decrease In Deferred Tax Assets Valuation Allowance
DecreaseInDeferredTaxAssetsValuationAllowance
|
0 | |
CY2017Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
14506000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13835000 | |
CY2018Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
8100000 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
1531000 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
0 | |
CY2017Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
0 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
11184000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
2680000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
696000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
0 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
14560000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
54000 | |
CY2018Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
54000 | |
CY2018 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="letter-spacing: 0px; font-family: "times new roman", times, serif; font-size: 10pt;;font-style:italic;display:inline;;font-style:italic;display:inline;">Reclassification</div></div><div style="color: rgb(0, 0, 0); font: 10pt "times new roman", times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"> </div><div style="color: rgb(0, 0, 0); font: 10pt "times new roman", times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px;">Certain amounts in the prior period consolidated financial statements have been reclassified to conform to the presentation of the current period consolidated financial statements. These reclassifications had no effect on the previously reported consolidated financial statements.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2018 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The process of preparing consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates include, but are not limited to, share-based compensation, valuation of warrant liability, accruals, depreciation and income taxes. Actual results could differ from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2018Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
54000 | |
CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
0 | |
CY2018Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 |